#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal achalasia Adult T-cell lymphoma/leukaemia refractory Chronic lymphocytic leukaemia refractory Vernal keratoconjunctivitis CDKL5 deficiency disorder Osteosarcoma metastatic Crigler-Najjar syndrome Tourette's disorder Hyperphagia Paget's disease of the vulva Blastic plasmacytoid dendritic cell neoplasia Angiosarcoma recurrent Primary myelofibrosis Obliterative bronchiolitis Hereditary hypophosphataemic rickets More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Treatment Systemic mastocytosis – Diagnostics Chronic granulomatous disease Mucopolysaccharidosis II – Basic Information Hereditary motor and sensory neuropathy Primary hyperoxaluria – Life with Disease Malignant fibrous histiocytoma – Treatment Factor VIII deficiency – Basic Information Fabry’s disease – Diagnostics Breast angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sorafenib 4-IODOPHENYLALANINE I-131 Encorafenib LUMC-BOB1-B7-TCR.1 Carbasalate Calcium Mps-216 Latanoprost Sertraline Hydrochloride Dexpanthenol CEFTAROLINE FOSAMIL Febuxostat Sulodexide Thiamazole Bms-986340 Enzalutamide Vrdn-001 LY3537031 Pimozide Ds-2325A Lanreotide More therapies…

    Learn about Your Condition

    Nodal osteoarthritis Medulloblastoma recurrent Iron overload Systemic lupus erythematosus Urea cycle disorder Sinus rhythm Allergic respiratory disease Pneumonia bacterial Univentricular heart Pancreatic carcinoma recurrent Immunodeficiency Hepatitis B Notalgia paraesthetica Fungal infection Low cardiac output syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psoriasis

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Jnj-77242113
    Germany Hungary Italy Poland Romania Spain

  • Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Jnj-77242113
    France Germany Hungary Italy Poland Spain

  • ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Germany Spain

  • A study to examine how the body processes and removes DC-806 in healthy male volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Dc-806
    • [14C] DC-806
    The Netherlands

  • Testing IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis

    Not recruiting

    2 1
    Investigated Drugs:
    • IDOR-1117-2520C
    Bulgaria Romania

  • Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Zasocitinib
    Bulgaria Czechia France Latvia Poland
Previous Page
1 2 3 4 5 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!